Cardiac POC Testing Devices Market
Cardiac POC Testing Devices Market Scope: Industry
Analysis, Market Size, Growth, Trends Till 2031
Request Sample Report
Cardiac POC Testing Devices Market Size and Growth
The Cardiac POC Testing Devices market is expanding due to rising cardiovascular diseases and demand for quick diagnostics. Valued at approximately $1.6 billion in 2022, it is projected to grow at a CAGR of around 8% over the next five years, driven by technological advancements and increasing healthcare access globally. Request Sample Report
Companies Covered
(Covid 19 Impact Covered)
◍ Roche Diagnostics
◍ Abaxis
◍ Abbott
◍ Beckman Coulter
◍ Beckton and Dickinson
◍ Bayer Diabetes Care
◍ Hemocue AB
◍ International Technidyne Corporation
◍ LifeScan Inc
◍ Nipro Diagnostics
◍ Orasure Technologies
◍ PointCare Technologies
◍ Siemens HealthCare Diagnostics
The cardiac point-of-care (POC) testing devices market is competitive, featuring companies like Roche, Abbott, and Siemens, which innovate diagnostic solutions. Collaborations enhance product offerings, while rapid tests drive adoption. Notable sales figures include Roche: ~$15 billion, Abbott: ~$10 billion, and Siemens: ~$7 billion, supporting market growth through technological advancements. Request Sample Report
Market Segmentation
By Application
Clinics
Hospitals ◍ Laboratories ◍ Others
By Product
◍ Troponin test
Brain natriuretic peptide test
Others
Request Sample Report
Market Growth
Request Sample Report
$ X Billion USD
